ABUQBEITAH, M. Et Al. 2018. Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer. NUCLEAR MEDICINE COMMUNICATIONS , vol.39, no.11 , 969-975.

ABUQBEITAH, M., DEMIR, M., KABASAKAL, L., CAVDAR, İ., Uslu-Beşli, L., YEYIN, N., ... RAZAVIKHOSROSHAHI, S.(2018). Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer. NUCLEAR MEDICINE COMMUNICATIONS , vol.39, no.11, 969-975.

ABUQBEITAH, M Et Al. "Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer," NUCLEAR MEDICINE COMMUNICATIONS , vol.39, no.11, 969-975, 2018

ABUQBEITAH, M Et Al. "Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer." NUCLEAR MEDICINE COMMUNICATIONS , vol.39, no.11, pp.969-975, 2018

ABUQBEITAH, M. Et Al. (2018) . "Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer." NUCLEAR MEDICINE COMMUNICATIONS , vol.39, no.11, pp.969-975.

@article{article, author={M ABUQBEITAH Et Al. }, title={Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer}, journal={NUCLEAR MEDICINE COMMUNICATIONS}, year=2018, pages={969-975} }